Search

everythinglearnresearchcommunity

for

Search:↓

Certain growth factors regulate hair growth cycles, male hormones affect hair cycles, and drugs like Minoxidil and Finasteride can stimulate hair growth and inhibit male pattern baldness respectively.

Overexpression of PTHrP in chondrocytes causes short-limbed dwarfism and delayed bone formation in mice.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

Some thymic peptides can increase human hair growth, while others may inhibit it.

Blocking certain brain processes reduces mating behavior in female rats.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

TRH stimulates human hair growth and extends the hair growth phase.

Blocking a specific receptor slows down hair loss in mice.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Targeting TRP channels may help reduce excessive scarring.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Adding a second method to PROTACs could improve cancer treatment.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Phenylephrine may help prevent hair loss from pulling on the hair roots.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.